Related references
Note: Only part of the references are listed.Lung Function, Radiological Findings and Biomarkers of Fibrogenesis in a Cohort of COVID-19 Patients Six Months After Hospital Discharge
Belen Safont et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2022)
High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection
Lucero A. Ramon-Luing et al.
LIFE-BASEL (2021)
Risk factors associated with the development of interstitial lung abnormalities
Ivette Buendia-Roldan et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile
Carlos Machahua et al.
THORAX (2021)
Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study
Benjamin Planquette et al.
THROMBOSIS RESEARCH (2021)
Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19
Jiezhong Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Emerging concepts in PD-1 checkpoint biology
Kristen E. Pauken et al.
SEMINARS IN IMMUNOLOGY (2021)
Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
Ruirong Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
PD-L1 Regulates Inflammation in LPS-Induced Lung Epithelial Cells and Vascular Endothelial Cells by Interacting with the HIF-1α Signaling Pathway
Shilong Zhao et al.
INFLAMMATION (2021)
Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China
Man Wang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
PD-L1 Dysregulation in COVID-19 Patients
Francesco Sabbatino et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection
Hyung J. Chun et al.
JCI INSIGHT (2021)
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study
Matthieu Schmidt et al.
INTENSIVE CARE MEDICINE (2021)
Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure
Jose Avendano-Ortiz et al.
MEDICINE (2020)
Immunological and inflammatory profiles in mild and severe cases of COVID-19
Jin-Wen Song et al.
NATURE COMMUNICATIONS (2020)
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans
Andrew Letizia et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Tim-3: A co-receptor with diverse roles in T cell exhaustion and tolerance
Ruihan Tang et al.
SEMINARS IN IMMUNOLOGY (2019)
Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies
Panagiotis Tsirigotis et al.
ANNALS OF MEDICINE (2016)
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
Asim Saha et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis
Annie Pardo et al.
RESPIRATORY RESEARCH (2016)
Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia
Shigeki Katoh et al.
LUNG (2015)
Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair
A. Davey et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
A genomic storm in critically injured humans
Wenzhong Xiao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)